Phase 1b Multicenter Study of Carfilzomib With Lenalidomide and Dexamethasone in Relapsed Multiple Myeloma

Clinical trial NCT00603447 · COMPLETED

Trial details

NCT number: NCT00603447
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsed Multiple Myeloma

Start date: 2008-05-01
Primary completion: 2013-05-01
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.